Sector
HealthcareOpen
₹226.23Prev. Close
₹226.23Turnover(Lac.)
₹500.39Day's High
₹230Day's Low
₹221.2652 Week's High
₹271.7252 Week's Low
₹96.9Book Value
₹36.61Face Value
₹1Mkt Cap (₹ Cr.)
4,956.6P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 21.81 | 21.81 | 14.54 | 49.65 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 823.57 | 831.64 | 461.44 | 352.01 |
Net Worth | 845.38 | 853.45 | 475.98 | 401.66 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 11.84 | 13.47 | 14.41 | 625.25 |
yoy growth (%) | -12.12 | -6.49 | -97.69 | 15.03 |
Raw materials | 0 | 0 | 0 | -153.7 |
As % of sales | 0 | 0 | 0 | 24.58 |
Employee costs | -17.46 | -15.28 | -14.59 | -58.73 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | -36.24 | -27.95 | -25.93 | 230.26 |
Depreciation | -4.39 | -4.34 | -4.16 | -21.3 |
Tax paid | 0 | 5.32 | 12.18 | -71.83 |
Working capital | -73.46 | 43.42 | -154.2 | 81.51 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -12.12 | -6.49 | -97.69 | 15.03 |
Op profit growth | 19.95 | -13.37 | -115.13 | 40.86 |
EBIT growth | 31.61 | 6.86 | -110.81 | 42.32 |
Net profit growth | 60.16 | 64.55 | -108.68 | 28.3 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 6.66 | 11.69 | 13.54 | 11.84 | 13.48 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 6.66 | 11.69 | 13.54 | 11.84 | 13.48 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 10.9 | 28.59 | 14.45 | 5.32 | 7.75 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,163 | 149.54 | 1,12,953.74 | 177.39 | 0.13 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,009.5 | 77.73 | 1,00,772.2 | 333.4 | 0.4 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 748.1 | 440.26 | 56,504.84 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 1,873.8 | 88.69 | 38,244.08 | 159.98 | 0.24 | 919.03 | 106.95 |
Global Health Ltd MEDANTA | 1,163 | 62.66 | 31,236.71 | 93.41 | 0.04 | 802.87 | 130.22 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & CEO
Venkateswarlu Jasti
Whole-time Director
Sudha Rani Jasti
Non Executive Director
Seyed E Hasnain
Independent Director
Santanu Mukherjee
Independent Director
J A S Padmaja
Company Sec. & Compli. Officer
Shrenik Soni
Independent Director
V Sambasiva Rao
#8-2-334 SDE Serene Chambers,
6 th Floor Road No 5 Avenue 7,
Telangana - 500034
Tel: 91-40-23541142/3311/3315
Website: http://www.suven.com
Email: info@suven.com; investorservices@suven.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989. The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limite...
Read More
Reports by Suven Life Sciences Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.